New Cochrane review confirms CST
New Cochrane review confirms the benefit and relevance of Cognitive Stimulation Therapy (CST) for people with dementia A 2nd systematic Cochrane review, ‘Cognitive stimulation to improve cognitive functioning in people with dementia’ (Woods et al., 2023), has been published. The systematic review further strengthens the scientific evidence base of CST, the main therapy for dementia that […]
Brain+ completes Swedish research version of its dementia product
Brain+ completes Swedish research version of its dementia product with the Research Institutes of Sweden and extends the collaboration A strong Swedish partner research network Brain+ has over the last three years entered multiple Alzheimer’s focused research and innovation projects with strong Swedish partners, including Research Institutes of Sweden (RISE), University of Gothenburg: Department of […]
3-Year Innovation Project is Completed
3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ has been completed. The project aimed to bring digital health solutions to people with dementia, in particular, solutions based on […]
WHO points to CST to solve the dementia burden
A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia Research, as its first initiative of this kind in the context of non-infectious diseases. In the report, WHO refers to […]
Leading dementia researcher joins Brain+
Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Rising star clinical dementia researcher to join the company in a new position as Clinical Director Recently, development was also strengthened with a Quality Manager and a Clinical Research Associate The new hires represent a significant […]
2021 Brain+ Annual Report
From the CEO: I am pleased with the Brain+ 2021 annual results we have presented today. With our commitment to develop medical software to detect and treat the cognitive symptoms of dementia, 2021 brought real progress. A few highlights: – Secured first strategic partnership with large pharma company in the main target market, Germany. – […]
